摘要
目的探讨固定剂量复合剂与板式组合药治疗处治涂阳肺结核效果。方法此次实验选择了我结防所2010年3月至2013年3月收治的初治涂阳肺结核患者100例,将患者随机分为对照组与观察组,各50例;对照组选择板式组合药治疗,观察组选择固定剂量复合剂治疗;比较两组患者各项实验数据。结果两组患者经不同方式治疗后,观察组临床治疗效果优于对照组,组间比较差异有统计学意义(P<0.05)。结论选择固定剂量复合剂治疗初治涂阳肺结核,临床治疗效果显著,值得临床广泛应用。
Objective To investigate the effect of fixed dose compound and plate combination therapy on smear positive pulmonary tuberculosis. Methods 100 patients with newly diagnosed smear-positive pulmonary tuberculosis were selected from March 2010 to March 2013. The patients were randomly divided into control group and observation group. Fifty patients in each group were treated with control group select the plate combination therapy, the observation group selected fixed dose compound therapy; compare the two groups of patients with experimental data. Results After treatment in different groups, the clinical treatment effect of the observation group was better than that of the control group, the difference was statistically significant(P <0.05). Conclusion The choice of fixed dose compound agent for the treatment of newly diagnosed smear positive pulmonary tuberculosis, clinical treatment effect is remarkable, worthy of clinical widely used.
出处
《中国医药指南》
2017年第18期14-14,16,共2页
Guide of China Medicine
关键词
固定剂量复合剂
板式组合药
初治涂阳肺结核
Fixed dose compound
Plate combination drug
Initial treatment of smear positive pulmonary tuberculosis
